Migseen Tablets (Miglitol)

Adult dose

Take as a single dose with a small amount of water before meals, or with a small amount of food. Adults: Initially, take 50 milligrams 3 times daily. Depending on tolerability, after 4-12 weeks of treatment, gradually increase the dose as usual to a maintenance dose of up to 100 milligrams 3 times daily.

This medication should not be used in certain patients. Those who are allergic to this medication or its excipients should not take it. Children and adolescents under 18 years old, as well as women who are pregnant or breastfeeding should not take this medication. Patients with intestinal disorders such as inflammatory bowel disease, colonic ulcer, localized intestinal obstruction, or those prone to bowel obstruction should also avoid this medication. Patients with chronic intestinal diseases accompanied by digestive disorders or malabsorption, or those with hernias who may experience increased intestinal gas leading to aggravated symptoms should be cautious. Patients with severely decreased kidney function, especially those with a creatinine clearance of 25ml/min or less, should not take this medication. This medication may increase the risk of hypoglycemia when taken with sulfonylureas, so dosage adjustments should be made when using both medications together. However, significant effects have not been observed in clinical trials. If hypoglycemic symptoms occur, treatment with glucose, a monosaccharide, is recommended. This medication contains the dye Yellow No. 5, so those allergic or hypersensitive to this component should be cautious when taking it. Upon ingestion, undigested carbohydrates may increase in the intestines, potentially leading to increased intestinal gas. Symptoms such as abdominal bloating, diarrhea, and abdominal pain may occur. These symptoms may depend on the dosage and food intake and may gradually alleviate over time. Adhering to a diabetic diet and avoiding foods containing sugar or sugars can reduce symptoms. If symptoms persist, it may be necessary to reduce the dosage or discontinue use. Rarely, symptoms such as nausea, constipation, and indigestion have also been reported. This medication may interact with other drugs, so caution is necessary when taking it concurrently. For example, using it with glibenclamide or metformin may affect the drug's effect or absorption. Additionally, it is advisable not to take it with intestinal adsorbents or some digestive enzymes. The laxative effect may be enhanced when used together with laxatives, and dosage adjustments may be necessary when used in combination with propranolol or ranitidine. Women who are pregnant or breastfeeding should not take this medication, and especially women who may become pregnant should avoid its use. In the case of an overdose, gastrointestinal disturbances may occur, so carbohydrate intake should be temporarily restricted, and diarrhea should be managed with standard treatment. This medication must be kept out of the reach of children, and transferring it to another container is not advisable for maintaining quality.

• Abdominal pain
• diarrhea
• abdominal distension
• loose stools
• abdominal fullness
• abdominal bloating
• nausea
• constipation
• dyspepsia
• vomiting

This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. This helps to ensure the medication's effectiveness lasts longer and can be used safely.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle